These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2179758)

  • 41. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of peritoneal transfer status on fasting blood glucose in non-diabetic nephropathy patients on continuous ambulatory peritoneal dialysis.
    Yu XF; Zhou YF; Feng L; Zhang DL; Liu WH
    Chin Med J (Engl); 2009 Dec; 122(24):2977-80. PubMed ID: 20137485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dialysate CA125 levels in children on continuous peritoneal dialysis.
    Turhan P; Sever L; Caliskan S; Kasapcopur O; Sever A; Hacibekiroglu M; Arisoy N
    Pediatr Nephrol; 2005 Nov; 20(11):1615-21. PubMed ID: 16133054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
    Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
    Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiological saline is not a biocompatible peritoneal dialysis solution.
    Wang T; Heimbürger O; Qureshi AR; Waniewski J; Bergström J; Lindholm B
    Int J Artif Organs; 1999 Feb; 22(2):88-93. PubMed ID: 10212043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
    Arfeen S; Goodship TH; Kirkwood A; Ward MK
    Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Encapsulating peritonitis during continuous ambulatory peritoneal dialysis. A physiopathologic hypothesis].
    Verger C; Celicout B; Larpent L; Goupil A
    Presse Med; 1986 Sep; 15(28):1311-4. PubMed ID: 2950390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment.
    Lahtela JT; Mustonen J; Pasternack A
    Clin Sci (Lond); 1995 Apr; 88(4):427-32. PubMed ID: 7789044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
    Gordon DL; Rice JL; Avery VM
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
    Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amino-acid-based continuous ambulatory peritoneal dialysis (CAPD) fluid over twelve weeks: effects on carbohydrate and lipid metabolism.
    Dibble JB; Young GA; Hobson SM; Brownjohn AM
    Perit Dial Int; 1990; 10(1):71-7. PubMed ID: 2085587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.
    Saint Paul LP; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Verdon R; Le Blanc E; Cattoir V; Lobbedez T
    Perit Dial Int; 2018; 38(6):463-466. PubMed ID: 30413641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An intraperitoneal insulin regimen for diabetics on continuous cyclic peritoneal dialysis.
    Aujla NS; Piraino B; Sorkin MI
    ASAIO Trans; 1990; 36(2):119-21. PubMed ID: 2187506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peritonitis rate: traditional versus low calcium dialysate.
    Stein A; Baker F; Moorhouse J; Walls J
    Am J Kidney Dis; 1995 Oct; 26(4):632-3. PubMed ID: 7573018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute metabolic effects of dialysis fluids during CAPD.
    Delarue J; Maingourd C
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S103-7. PubMed ID: 11158872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.